- Home
- / Beta Bionics
Beta Bionics
Revenue
$100.3 M
FY, 2025
Beta Bionics Summary
Company Summary
- Overview
- Beta Bionics is a company that provides clinical-stage medical technology solutions. It designs, develops, and commercialises iLet Bionic Pancreas, an insulin delivery system for type 1 diabetes (T1D) for adults and children.
- Type
- Public
- Status
- Active
- Founded
- 2015
- HQ
- Irvine, CA, US | view all locations
- Website
- https://www.betabionics.com
- Cybersecurity rating
Table of Contents
Key People
Joe Conkey, VP, Quality Assurance
Firas El-Khatib, VP, Research & Innovation
Ed Damiano, Founder, Executive Chair
LocationsView all
1 location detected
Irvine, CA HQ
United States
11 Hughes
Beta Bionics Financials
Summary Financials
- Revenue (Q1, 2026)
- $27.6M
- Gross profit (Q1, 2026)
- $16.4M
- Net income (Q1, 2026)
- ($21.9M)
- Cash (Q1, 2026)
- $30.2M
- EBIT (Q1, 2026)
- ($24.3M)